Jin Medical International annual free cash flow
2021
2022
2023
2024
2025
Jin Medical International reported −$3.7M in free cash flow for fiscal 2025, a decrease of $2.4M from the previous fiscal year, with a free cash flow margin of −18.01%.
View full Jin Medical International company overview| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-09-30 | −$3.7M | −$2.4M | — | −18.01% |
| 2024 | 2024-09-30 | −$1.4M | −$4.3M | — | −5.75% |
| 2023 | 2023-09-30 | $3.0M | $1.5M | +94.25% | +15.10% |
| 2022 | 2022-09-30 | $1.5M | −$4.3M | −73.44% | +8.03% |
| 2021 | 2021-09-30 | $5.8M | — | — | +27.93% |
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Jin Medical International filings at SEC.gov ↗